Aug. 8, 2022
Auron Therapeutics, a biopharmaceutical company focused on developing therapies that target dysregulated differentiation and cellular plasticity for treating cancer, just …
Aug. 2, 2022
Canada has established itself as a rapidly growing global hub for artificial intelligence (AI) innovation and commercialization. This roots deep …
July 12, 2022
Receptor.AI, a UK-based start-up company which integrates artificial intelligence (AI) into drug discovery, just announced the public launch of the …
July 6, 2022
It took more than eight decades since the landmark experiments on calorie restrictions in 1930th to get to a point …
May 6, 2022
As of now, only 5% of so-called rare diseases (orphan diseases) have an FDA-approved treatment available to patients. Rare diseases …
May 4, 2022
Ever since the early 2000s, Artificial Intelligence (AI) has become a useful tool in various fields, from game design and …
April 25, 2022
What is “artificial intelligence”? Artificial intelligence (AI) is an interdisciplinary science concerned with building “intelligent agents”, the field which takes …
April 14, 2022
Dr. Tony Kulesa is the co-founder of Petri, an organization that both invests in early-stage biotech startups and works 1-on-1 …
April 7, 2022
The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% …
March 22, 2022
Sponsored by PharmCADD
The application of Artificial Intelligence (AI) to accelerate and improve drug discovery has been a growing trend for several years …
Feb. 4, 2022
The BRD4 (Bromodomain-containing protein 4) protein is a transcriptional factor that plays an important role in cancer development. It has …
Jan. 26, 2022
Artificial Intelligence (AI) in drug discovery is now on a steep rise. A growing number of companies compete to develop …
